亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購(gòu)物車(chē)
企業(yè)會(huì)員第1年

武漢遠(yuǎn)城科技發(fā)展有限公司銷(xiāo)售八部  

肉桂酸、肉桂醛、肉桂醇、及公司經(jīng)營(yíng)的生物化工、醫(yī)藥中間體等產(chǎn)品

搜索
新聞中心
  • 暫無(wú)新聞
產(chǎn)品分類(lèi)
  • 暫無(wú)分類(lèi)
聯(lián)系方式
  • 聯(lián)系人:劉
  • 電話(huà):02788320827
  • 郵件:yucheng011@yuanchengdope.com
  • 傳真:02788048077
  • QQ:172616357
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無(wú)鏈接
貝諾酯
單價(jià) 面議對(duì)比
詢(xún)價(jià) 暫無(wú)
發(fā)貨 湖北武漢市付款后3天內(nèi)
過(guò)期 長(zhǎng)期有效
更新 2011-04-16 11:43
 
詳細(xì)信息

貝諾酯
英文名: Benorilate
別名:撲炎痛,撲熱痛,解熱安,酰胺水楊酯,苯樂(lè)來(lái),F(xiàn)enasprate,
Benoral,Salipran,Winolate。
化學(xué)名:對(duì)乙酰氨基酚乙酰水楊酸酯;2-乙酰氧基苯甲酸-4-乙酰氨基苯酯
含量:99% 
分子式:C17H15NO5 
分子量:313.3 
CAS登記號(hào):5003-48-5 
熔點(diǎn):177~181℃。
執(zhí)行標(biāo)準(zhǔn):CP/USP/BP
包裝:25kg/桶 
性狀:白色結(jié)晶或結(jié)晶性粉末;無(wú)臭,無(wú)味,幾乎不溶于水。 
主要用途: 對(duì)乙酰氨基酚與阿司匹林的酯化物,新型的消炎、解熱、鎮(zhèn)痛、
治療風(fēng)濕病的藥物。本品具有解熱、鎮(zhèn)痛及抗炎作用。用于發(fā)熱、 頭痛、神
經(jīng)痛、牙痛及手術(shù)后輕中度疼痛等。 
Benorilate
Synonyms: pain, inflammation flutter, flutter and heat pain, fever
 security, salicylic ester amide, benzene music to, Fenasprate,
 Benoral, Salipran, Winolate.
Chemical name: acetaminophen acetylsalicylic acid ester; 
2 - acetoxy-benzoic acid -4-- phenyl acetamide
Content: 99%
Molecular formula: C17H15NO5
Molecular weight: 313.3
CAS Registry Number :5003 -48-5
Melting point: 177 ~ 181 ℃.
Executive Standard: CP / USP / BP
Packing: 25kg cardboard drum
Properties: white crystal or crystalline powder; odorless,
 tasteless, almost insoluble in water.
Main purpose: acetaminophen and aspirin esters, a new type 
of anti-inflammatory, antipyretic, analgesic, a drug to treat
 rheumatism. This product has antipyretic, analgesic and 
anti-inflammatory effect. For fever, headache, God
Menstrual pain, toothache, and mild to moderate pain after surgery.

 

©2025 武漢遠(yuǎn)城科技發(fā)展有限公司銷(xiāo)售八部 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪(fǎng)問(wèn)量:27684  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |